Prothena Shares Outstanding 2011-2024 | PRTA

Prothena shares outstanding from 2011 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Prothena Annual Shares Outstanding
(Millions of Shares)
2023 53
2022 47
2021 48
2020 40
2019 40
2018 40
2017 38
2016 34
2015 30
2014 25
2013 19
2012 15
2011 14
2010 14
Prothena Quarterly Shares Outstanding
(Millions of Shares)
2024-06-30 55
2024-03-31 54
2023-12-31 53
2023-09-30 58
2023-06-30 53
2023-03-31 53
2022-12-31 47
2022-09-30 47
2022-06-30 47
2022-03-31 47
2021-12-31 48
2021-09-30 51
2021-06-30 47
2021-03-31 40
2020-12-31 40
2020-09-30 40
2020-06-30 40
2020-03-31 40
2019-12-31 40
2019-09-30 40
2019-06-30 40
2019-03-31 40
2018-12-31 40
2018-09-30 40
2018-06-30 40
2018-03-31 39
2017-12-31 38
2017-09-30 38
2017-06-30 38
2017-03-31 36
2016-12-31 34
2016-09-30 34
2016-06-30 34
2016-03-31 34
2015-12-31 30
2015-09-30 31
2015-06-30 31
2015-03-31 27
2014-12-31 25
2014-09-30 27
2014-06-30 23
2014-03-31 23
2013-12-31 19
2013-09-30 18
2013-06-30 18
2013-03-31 18
2012-12-31 15
2012-09-30 14
2012-06-30 14
2012-03-31 14
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.898B $0.091B
Prothena Corp. plc, being a clinical-stage neuroscience company, focused on the development of novel therapeutic therapies for life-threatening diseases. Its wholly owned programs include birtamimab for the potential treatment of AL amyloidosis, PRX004 for the potential treatment of ATTR amyloidosis and a portfolio of programs for the potential treatment of Alzheimer's disease including PRX012 that targets A?.?Prothena is also developing candidates in collaboration with bigwigs like Roche and Bristol-Myers Squibb. These programs include prasinezumab, in collaboration with Roche for the potential treatment of Parkinson's disease and other related synucleinopathies, and programs that target tau, TDP-43 and an undisclosed target in collaboration with Bristol-Myers Squibb for the potential treatment of Alzheimer's disease, amyotrophic lateralsclerosis, etc. It sold PRX004 and the broader ATTR amyloidosis program to Novo Nordisk. It derives revenues from license, development & commercialization agreements.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $170.699B 17.08
Vertex Pharmaceuticals (VRTX) United States $118.453B 0.00
Regeneron Pharmaceuticals (REGN) United States $110.814B 26.17
Bristol Myers Squibb (BMY) United States $106.398B 38.31
Gilead Sciences (GILD) United States $106.086B 18.13
CSL (CSLLY) Australia $95.670B 0.00
GSK (GSK) United Kingdom $78.798B 9.14
Alnylam Pharmaceuticals (ALNY) United States $34.816B 0.00
Argenex SE (ARGX) Netherlands $31.522B 0.00
BioNTech SE (BNTX) Germany $28.603B 0.00
Biogen (BIIB) United States $26.554B 11.21
BeiGene (BGNE) Cayman Islands $22.890B 0.00
Moderna (MRNA) United States $22.445B 0.00
Illumina (ILMN) United States $22.248B 151.80
Genmab (GMAB) Denmark $15.608B 19.50
BioMarin Pharmaceutical (BMRN) United States $13.043B 38.59
Exact Sciences (EXAS) United States $12.670B 0.00
Incyte (INCY) United States $12.661B 821.75
Vaxcyte (PCVX) United States $12.472B 0.00
Insmed (INSM) United States $12.265B 0.00
Bio-Techne Corp (TECH) United States $11.699B 45.80
Sarepta Therapeutics (SRPT) United States $11.417B 260.26
QIAGEN (QGEN) Netherlands $9.941B 20.99
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Legend Biotech (LEGN) United States $8.762B 0.00
Roivant Sciences (ROIV) United Kingdom $8.342B 0.00
Revolution Medicines (RVMD) United States $8.314B 0.00
Ascendis Pharma (ASND) Denmark $8.008B 0.00
Intra-Cellular Therapies (ITCI) United States $7.649B 0.00
Repligen (RGEN) United States $7.562B 115.40
Viking Therapeutics (VKTX) United States $7.388B 0.00
Exelixis (EXEL) United States $7.243B 22.27
Halozyme Therapeutics (HALO) United States $6.857B 18.04
Nuvalent (NUVL) United States $6.635B 0.00
Cytokinetics (CYTK) United States $6.392B 0.00
Zealand Pharma (ZLDPF) Denmark $6.066B 0.00
Blueprint Medicines (BPMC) United States $5.541B 0.00
Avidity Biosciences (RNA) United States $5.087B 0.00
Biohaven (BHVN) United States $5.063B 0.00
Krystal Biotech (KRYS) United States $5.023B 336.23
Ultragenyx Pharmaceutical (RARE) United States $4.912B 0.00
ADMA Biologics Inc (ADMA) United States $4.829B 79.69
Alkermes (ALKS) Ireland $4.464B 15.67
Arcellx (ACLX) United States $4.346B 0.00
Immunovant (IMVT) United States $4.334B 0.00
Axsome Therapeutics (AXSM) United States $4.029B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.844B 0.00
Denali Therapeutics (DNLI) United States $3.827B 0.00
Merus (MRUS) Netherlands $3.614B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.592B 0.00
Apellis Pharmaceuticals (APLS) United States $3.336B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.185B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.108B 0.00
Amicus Therapeutics (FOLD) United States $2.978B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.940B 0.00
Iovance Biotherapeutics (IOVA) United States $2.720B 0.00
Edgewise Therapeutics (EWTX) United States $2.672B 0.00
Kymera Therapeutics (KYMR) United States $2.658B 0.00
IDEAYA Biosciences (IDYA) United States $2.624B 0.00
Guardant Health (GH) United States $2.590B 0.00
Protagonist Therapeutics (PTGX) United States $2.589B 16.78
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.581B 0.00
Geron (GERN) United States $2.574B 0.00
Apogee Therapeutics (APGE) United States $2.525B 0.00
Bavarian Nordic (BVNRY) Denmark $2.502B 13.51
Twist Bioscience (TWST) United States $2.492B 0.00
Zai Lab (ZLAB) China $2.474B 0.00
ImmunityBio (IBRX) United States $2.452B 0.00
SpringWorks Therapeutics (SWTX) United States $2.407B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.399B 80.33
Scholar Rock Holding (SRRK) United States $2.360B 0.00
Neumora Therapeutics (NMRA) United States $2.359B 0.00
Myriad Genetics (MYGN) United States $2.358B 0.00
Janux Therapeutics (JANX) United States $2.344B 0.00
CG Oncology (CGON) United States $2.336B 0.00
Structure Therapeutics (GPCR) United States $2.316B 0.00
Keros Therapeutics (KROS) United States $2.239B 0.00
Vera Therapeutics (VERA) United States $2.119B 0.00
Novavax (NVAX) United States $2.088B 0.00
Vericel (VCEL) United States $2.027B 0.00
Celldex Therapeutics (CLDX) United States $2.025B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.975B 17.82
Galapagos (GLPG) Belgium $1.960B 0.00
Akero Therapeutics (AKRO) United States $1.954B 0.00
Beam Therapeutics (BEAM) United States $1.917B 0.00
Ligand Pharmaceuticals (LGND) United States $1.881B 31.98
Mirum Pharmaceuticals (MIRM) United States $1.856B 0.00
Intellia Therapeutics (NTLA) United States $1.817B 0.00
Certara (CERT) United States $1.808B 59.16
MannKind (MNKD) United States $1.776B 64.60
Arvinas (ARVN) United States $1.770B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.743B 0.00
NeoGenomics (NEO) United States $1.722B 0.00
Fortrea Holdings (FTRE) United States $1.673B 51.86
Belite Bio (BLTE) United States $1.651B 0.00
Arcus Biosciences (RCUS) United States $1.597B 0.00
NovoCure (NVCR) Jersey $1.586B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.570B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.564B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.529B 0.00
Viridian Therapeutics (VRDN) United States $1.495B 0.00
Disc Medicine (IRON) United States $1.424B 0.00
Spyre Therapeutics (SYRE) United States $1.420B 0.00
Nurix Therapeutics (NRIX) United States $1.417B 0.00
Dynavax Technologies (DVAX) United States $1.393B 96.64
Kura Oncology (KURA) United States $1.392B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.308B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.293B 0.00
Gyre Therapeutics (GYRE) United States $1.207B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.201B 0.00
ANI Pharmaceuticals (ANIP) United States $1.195B 16.23
Cogent Biosciences (COGT) United States $1.188B 0.00
Bicara Therapeutics (BCAX) $1.167B 0.00
Travere Therapeutics (TVTX) United States $1.163B 0.00
Praxis Precision Medicines (PRAX) United States $1.150B 0.00
Tyra Biosciences (TYRA) United States $1.143B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.132B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.118B 0.00
Mesoblast (MESO) Australia $1.090B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.080B 0.00
Vir Biotechnology (VIR) United States $1.000B 0.00
WAVE Life Sciences (WVE) Singapore $0.998B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.982B 0.00
Applied Therapeutics (APLT) United States $0.941B 0.00
Cullinan Therapeutics (CGEM) United States $0.934B 0.00
Immatics (IMTX) Germany $0.929B 0.00
ArriVent BioPharma (AVBP) United States $0.920B 0.00
Sana Biotechnology (SANA) United States $0.908B 0.00
Zymeworks (ZYME) United States $0.890B 0.00
AnaptysBio (ANAB) United States $0.887B 0.00
CARGO Therapeutics (CRGX) United States $0.873B 0.00
IGM Biosciences (IGMS) United States $0.863B 0.00
Liquidia Technologies (LQDA) United States $0.846B 0.00
Castle Biosciences (CSTL) United States $0.828B 0.00
MiMedx (MDXG) United States $0.822B 23.33
Dianthus Therapeutics (DNTH) United States $0.822B 0.00
Replimune (REPL) United States $0.802B 0.00
Immunome (IMNM) United States $0.775B 0.00
Adaptive Biotechnologies (ADPT) United States $0.774B 0.00
AbCellera Biologics (ABCL) Canada $0.757B 0.00
Tango Therapeutics (TNGX) United States $0.738B 0.00
89BIO (ETNB) United States $0.729B 0.00
Annexon (ANNX) United States $0.728B 0.00
Rapport Therapeutics (RAPP) United States $0.721B 0.00
Erasca (ERAS) United States $0.712B 0.00
Arbutus Biopharma (ABUS) United States $0.712B 0.00
Zenas BioPharma (ZBIO) $0.704B 0.00
MBX Biosciences (MBX) $0.696B 0.00
Pliant Therapeutics (PLRX) United States $0.683B 0.00
Mineralys Therapeutics (MLYS) United States $0.676B 0.00
LENZ Therapeutics (LENZ) United States $0.671B 0.00
Oric Pharmaceuticals (ORIC) United States $0.669B 0.00
Cytek Biosciences (CTKB) United States $0.663B 0.00
Humacyte (HUMA) United States $0.662B 0.00
Avid Bioservices (CDMO) United States $0.660B 0.00
Neurogene (NGNE) United States $0.654B 0.00
Olema Pharmaceuticals (OLMA) United States $0.653B 0.00
CureVac (CVAC) Germany $0.647B 0.00
Stoke Therapeutics (STOK) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Astria Therapeutics (ATXS) United States $0.633B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.630B 0.00
Oculis Holding AG (OCS) Switzerland $0.612B 0.00
Entrada Therapeutics (TRDA) United States $0.610B 5.54
Arcturus Therapeutics Holdings (ARCT) United States $0.605B 0.00
Pharming Group (PHAR) Netherlands $0.591B 0.00
Abivax SA (ABVX) France $0.578B 0.00
Allogene Therapeutics (ALLO) United States $0.573B 0.00
Celcuity (CELC) United States $0.565B 0.00
Nuvation Bio (NUVB) United States $0.556B 0.00
Terns Pharmaceuticals (TERN) United States $0.549B 0.00
Revance Therapeutics (RVNC) United States $0.547B 0.00
CorMedix Inc (CRMD) United States $0.540B 0.00
Q32 Bio (QTTB) United States $0.540B 0.00
Cartesian Therapeutics (RNAC) United States $0.516B 0.00
Third Harmonic Bio (THRD) United States $0.510B 0.00
Emergent Biosolutions (EBS) United States $0.488B 0.00
Alumis (ALMS) United States $0.487B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.483B 0.00
PureTech Health (PRTC) United States $0.482B 0.00
REGENXBIO (RGNX) United States $0.472B 0.00
Tectonic Therapeutic (TECX) United States $0.471B 0.00
ACELYRIN, INC (SLRN) United States $0.470B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.464B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.454B 0.00
Prime Medicine (PRME) United States $0.454B 0.00
Alector (ALEC) United States $0.451B 0.00
Absci (ABSI) United States $0.447B 0.00
Anavex Life Sciences (AVXL) United States $0.444B 0.00
Contineum Therapeutics (CTNM) United States $0.442B 0.00
Foghorn Therapeutics (FHTX) United States $0.421B 0.00
Aura Biosciences (AURA) United States $0.419B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.414B 0.00
Biomea Fusion (BMEA) United States $0.413B 0.00
MaxCyte (MXCT) United States $0.408B 0.00
GRAIL (GRAL) United States $0.404B 0.00
Northwest Biotherapeutics (NWBO) United States $0.391B 0.00
Voyager Therapeutics (VYGR) United States $0.386B 25.29
Mind Medicine (MindMed) (MNMD) United States $0.381B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.372B 0.00
Anika Therapeutics (ANIK) United States $0.365B 176.00
Artiva Biotherapeutics (ARTV) United States $0.361B 0.00
C4 Therapeutics (CCCC) United States $0.356B 0.00
Fate Therapeutics (FATE) United States $0.350B 0.00
ITeos Therapeutics (ITOS) United States $0.344B 0.00
Nautilus Biotechnology (NAUT) United States $0.337B 0.00
GH Research (GHRS) Ireland $0.335B 0.00
Inozyme Pharma (INZY) United States $0.329B 0.00
AC Immune (ACIU) Switzerland $0.327B 0.00
XOMA Royalty (XOMA) United States $0.321B 0.00
PepGen (PEPG) United States $0.318B 0.00
EnGene Holdings (ENGN) Canada $0.314B 0.00
Urogen Pharma (URGN) United States $0.307B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.307B 0.00
Alto Neuroscience (ANRO) United States $0.303B 0.00
Kamada (KMDA) Israel $0.302B 19.48
ADC Therapeutics SA (ADCT) Switzerland $0.297B 0.00
TScan Therapeutics (TCRX) United States $0.296B 0.00
Sutro Biopharma (STRO) United States $0.289B 0.00
UniQure (QURE) Netherlands $0.288B 0.00
Atea Pharmaceuticals (AVIR) United States $0.288B 0.00
Zura Bio (ZURA) United States $0.283B 0.00
Abeona Therapeutics (ABEO) United States $0.283B 0.00
GENFIT S.A (GNFT) France $0.279B 0.00
Design Therapeutics (DSGN) United States $0.279B 0.00
Ocugen (OCGN) United States $0.276B 0.00
Nkarta (NKTX) United States $0.275B 0.00
Solid Biosciences (SLDB) United States $0.273B 0.00
Opthea (OPT) Australia $0.270B 0.00
MeiraGTx Holdings (MGTX) United States $0.269B 0.00
Rezolute (RZLT) United States $0.265B 0.00
Alpha Teknova (TKNO) United States $0.264B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 0.00
Editas Medicine (EDIT) United States $0.261B 0.00
Poseida Therapeutics (PSTX) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Amarin (AMRN) Ireland $0.244B 0.00
Mersana Therapeutics (MRSN) United States $0.244B 0.00
2seventy Bio (TSVT) United States $0.244B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Jasper Therapeutics (JSPR) United States $0.240B 0.00
Compass Therapeutics (CMPX) United States $0.238B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.232B 0.00
Instil Bio (TIL) United States $0.232B 0.00
Inhibrx Biosciences (INBX) United States $0.231B 0.00
Gossamer Bio (GOSS) United States $0.231B 0.00
Trevi Therapeutics (TRVI) United States $0.229B 0.00
Fulcrum Therapeutics (FULC) United States $0.221B 0.00
Codexis (CDXS) United States $0.218B 0.00
Precigen (PGEN) United States $0.216B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.216B 0.00
Cabaletta Bio (CABA) United States $0.212B 0.00
XBiotech (XBIT) United States $0.210B 0.00
Black Diamond Therapeutics (BDTX) United States $0.201B 0.00
ScPharmaceuticals (SCPH) United States $0.199B 0.00
DiaMedica Therapeutics (DMAC) United States $0.199B 0.00
Kyverna Therapeutics (KYTX) United States $0.198B 0.00
Candel Therapeutics (CADL) United States $0.197B 0.00
Eton Pharmaceuticals (ETON) United States $0.191B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.188B 0.00
Molecular Partners AG (MOLN) Switzerland $0.180B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Innate Pharma S.A (IPHA) France $0.173B 0.00
Caribou Biosciences (CRBU) United States $0.171B 0.00
BioStem Technologies (BSEM) $0.169B 26.53
Sangamo Therapeutics (SGMO) United States $0.168B 0.00
Scilex Holding (SCLX) United States $0.161B 0.00
Adverum Biotechnologies (ADVM) United States $0.158B 0.00
Generation Bio (GBIO) United States $0.155B 0.00
Compugen (CGEN) Israel $0.154B 0.00
Akoya Biosciences (AKYA) United States $0.153B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.153B 0.00
Lifecore Biomedical (LFCR) United States $0.149B 0.00
Inovio Pharmaceuticals (INO) United States $0.148B 0.00
ATyr Pharma (ATYR) United States $0.147B 0.00
Repare Therapeutics (RPTX) Canada $0.146B 0.00
Ventyx Biosciences (VTYX) United States $0.145B 0.00
23andMe Holding (ME) United States $0.144B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.142B 0.00
Immunic (IMUX) United States $0.141B 0.00
Kodiak Sciences (KOD) United States $0.139B 0.00
Tenaya Therapeutics (TNYA) United States $0.136B 0.00
Vigil Neuroscience (VIGL) United States $0.136B 0.00
Actuate Therapeutics (ACTU) United States $0.136B 0.00
Seres Therapeutics (MCRB) United States $0.131B 0.00
PDS Biotechnology (PDSB) United States $0.131B 0.00
Elutia (ELUT) United States $0.130B 0.00
Puma Biotechnology (PBYI) United States $0.129B 13.79
Cardiff Oncology (CRDF) United States $0.128B 0.00
Adherex Technologies (FENC) United States $0.124B 112.75
Oncobiologics (OTLK) United States $0.123B 0.00
Sagimet Biosciences (SGMT) United States $0.122B 0.00
Coherus BioSciences (CHRS) United States $0.120B 0.00
Seer (SEER) United States $0.119B 0.00
Adicet Bio (ACET) United States $0.118B 0.00
Verastem (VSTM) United States $0.118B 0.00
Skye Bioscience (SKYE) United States $0.117B 0.00
Rani Therapeutics Holdings (RANI) United States $0.117B 0.00
Nuvectis Pharma (NVCT) United States $0.112B 0.00
I-Mab (IMAB) China $0.111B 0.00
Clearside Biomedical (CLSD) United States $0.111B 0.00
Cellectis S.A (CLLS) France $0.109B 0.00
Annovis Bio (ANVS) United States $0.109B 0.00
Invivyd (IVVD) United States $0.108B 0.00
Checkpoint Therapeutics (CKPT) United States $0.107B 0.00
Coya Therapeutics (COYA) United States $0.107B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.104B 0.00
Benitec Biopharma (BNTC) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.099B 0.00
BioAtla (BCAB) United States $0.099B 0.00
Adagene (ADAG) China $0.099B 0.00
Agenus (AGEN) United States $0.098B 0.00
Oncolytics Biotech (ONCY) Canada $0.098B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.097B 0.00
FibroBiologics (FBLG) United States $0.097B 0.00
MediciNova (MNOV) United States $0.096B 0.00
Bluebird Bio (BLUE) United States $0.094B 0.00
BeyondSpring (BYSI) United States $0.092B 0.00
X4 Pharmaceuticals (XFOR) United States $0.091B 0.00
Genenta Science S.p.A (GNTA) Italy $0.091B 0.00
HilleVax (HLVX) United States $0.090B 0.00
CytomX Therapeutics (CTMX) United States $0.089B 8.14
InflaRx (IFRX) Germany $0.088B 0.00
Genelux (GNLX) United States $0.088B 0.00
BioHarvest Sciences (CNVCF) Canada $0.088B 0.00
Inventiva S.A (IVA) France $0.087B 0.00
ALX Oncology Holdings (ALXO) United States $0.087B 0.00
Werewolf Therapeutics (HOWL) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
CervoMed (CRVO) United States $0.082B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.082B 0.00
VistaGen Therapeutics (VTGN) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.078B 0.00
Ovid Therapeutics (OVID) United States $0.078B 0.00
Chimerix (CMRX) United States $0.078B 0.00
IO Biotech (IOBT) Denmark $0.076B 0.00
Cidara Therapeutics (CDTX) United States $0.075B 0.00
Aileron Therapeutics (ALRN) United States $0.075B 0.00
Adlai Nortye (ANL) Cayman Islands $0.073B 0.00
Immuneering (IMRX) United States $0.071B 0.00
Connect Biopharma Holdings (CNTB) United States $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.068B 0.00
DBV Technologies S.A (DBVT) France $0.068B 0.00
Boundless Bio (BOLD) United States $0.068B 0.00
Spero Therapeutics (SPRO) United States $0.067B 3.02
Precision BioSciences (DTIL) United States $0.066B 0.00
Rapt Therapeutics (RAPT) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.063B 0.00
TELA Bio (TELA) United States $0.062B 0.00
Leap Therapeutics (LPTX) United States $0.061B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.061B 0.00
Renovaro (RENB) United States $0.061B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Imunon (IMNN) United States $0.060B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Aerovate Therapeutics (AVTE) United States $0.059B 0.00
Omega Therapeutics (OMGA) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Allakos (ALLK) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Syros Pharmaceuticals (SYRS) United States $0.054B 0.00
Semper Paratus Acquisition (TVGN) United States $0.054B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.053B 0.00
Celularity (CELU) United States $0.052B 0.00
Intensity Therapeutics (INTS) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
Elicio Therapeutics (ELTX) United States $0.050B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.049B 0.00
Lexaria Bioscience (LEXX) Canada $0.048B 0.00
Aadi Bioscience (AADI) United States $0.048B 0.00
Affimed (AFMD) Germany $0.048B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.048B 0.00
HOOKIPA Pharma (HOOK) United States $0.047B 0.00
Vor Biopharma (VOR) $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Immix Biopharma (IMMX) United States $0.042B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
NextCure (NXTC) United States $0.039B 0.00
Atara Biotherapeutics (ATRA) United States $0.039B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.038B 0.00
Passage Bio (PASG) United States $0.038B 0.00
LakeShore Biopharma (LSB) China $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Bionano Genomics (BNGO) United States $0.036B 0.00
Clene (CLNN) United States $0.035B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Dyadic (DYAI) United States $0.035B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.034B 0.00
Ocuphire Pharma (OCUP) United States $0.034B 0.00
Equillium (EQ) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
BRIACELL THERAP (BCTX) Canada $0.033B 0.00
Xilio Therapeutics (XLO) United States $0.033B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
Lumos Pharma (LUMO) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Elevation Oncology (ELEV) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Quince Therapeutics (QNCX) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
Longeveron (LGVN) United States $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
KALA BIO (KALA) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
Gritstone Bio (GRTS) United States $0.024B 0.00
BioAffinity Technologies (BIAF) United States $0.024B 0.00
Aligos Therapeutics (ALGS) United States $0.023B 0.00
BioXcel Therapeutics (BTAI) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Biora Therapeutics (BIOR) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.019B 0.00
HCW Biologics (HCWB) United States $0.019B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
Monopar Therapeutics (MNPR) United States $0.019B 0.00
Spruce Biosciences (SPRB) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
Evaxion Biotech (EVAX) Denmark $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Cadrenal Therapeutics (CVKD) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Apollomics (APLM) United States $0.013B 0.00
Vincerx Pharma (VINC) United States $0.012B 0.00
NKGen Biotech (NKGN) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Evogene (EVGN) Israel $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.011B 0.00
Senti Biosciences (SNTI) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Kintara Therapeutics (KTRA) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Carmell (CTCX) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
NuCana (NCNA) United Kingdom $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Vaccinex (VCNX) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Bionomics (BNOX) Australia $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00